Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Minority Interest (2020 - 2022)

Cullinan Therapeutics has reported Minority Interest over the past 3 years, most recently at $80000.0 for Q2 2022.

  • Quarterly results put Minority Interest at $80000.0 for Q2 2022, down 97.33% from a year ago — trailing twelve months through Jun 2022 was $80000.0 (down 97.33% YoY), and the annual figure for FY2021 was $403000.0, down 69.1%.
  • Minority Interest for Q2 2022 was $80000.0 at Cullinan Therapeutics, down from $768000.0 in the prior quarter.
  • Over the last five years, Minority Interest for CGEM hit a ceiling of $3.0 million in Q2 2021 and a floor of $80000.0 in Q2 2022.
  • Median Minority Interest over the past 3 years was $1.3 million (2020), compared with a mean of $1.5 million.
  • Biggest five-year swings in Minority Interest: soared 135.7% in 2021 and later plummeted 97.33% in 2022.
  • Cullinan Therapeutics' Minority Interest stood at $1.3 million in 2020, then crashed by 69.1% to $403000.0 in 2021, then tumbled by 80.15% to $80000.0 in 2022.
  • The last three reported values for Minority Interest were $80000.0 (Q2 2022), $768000.0 (Q1 2022), and $403000.0 (Q4 2021) per Business Quant data.